Cargando…

Re-Evaluation of Clinical Dementia Diagnoses with Pittsburgh Compound B Positron Emission Tomography

OBJECTIVES: There is an overlap regarding Pittsburgh compound B (PIB) retention in patients clinically diagnosed as Alzheimer's disease (AD) and non-AD dementia. The aim of the present study was to investigate whether there are any differences between PIB-positive and PIB-negative patients in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Degerman Gunnarsson, M., Lindau, M., Santillo, A.F., Wall, A., Engler, H., Lannfelt, L., Basun, H., Kilander, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2013
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919484/ https://www.ncbi.nlm.nih.gov/pubmed/24516415 http://dx.doi.org/10.1159/000356273

Ejemplares similares

High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease
por: Degerman Gunnarsson, Malin, et al.
Publicado: (2016)

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease
por: Kadir, Ahmadul, et al.
Publicado: (2011)

Positron emission tomography imaging of dementia
por: Small, Gary W.
Publicado: (2000)

Positron Emission Tomography (PET) utilizing Pittsburgh compound B (PIB) detects amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
por: Pilebro, Björn, et al.
Publicado: (2015)

(11)C-Pittsburgh compound B and (18)F-THK 5351 positron emission tomography brain imaging in cognitively normal individuals
por: Chotipanich, Chanisa, et al.
Publicado: (2020)

Alzheimer’s Dementia: The Emerging Role of Positron Emission Tomography
por: Tripathi, Shailendra Mohan, et al.
Publicado: (2021)

[(18)F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes
por: Santillo, Alexander F., et al.
Publicado: (2022)

Amyloid deposition in semantic dementia: a positron emission tomography study
por: Brown, Eric E., et al.
Publicado: (2016)

Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies
por: Chen, Qin, et al.
Publicado: (2022)

(18)F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies
por: Graff-Radford, Jonathan, et al.
Publicado: (2020)

Diagnostic Utility of Integrated (11)C-Pittsburgh Compound B Positron Emission Tomography/Magnetic Resonance for Cerebral Amyloid Angiopathy: A Pilot Study
por: Chang, Yan, et al.
Publicado: (2021)

A case of sarcoidosis diagnosed by positron emission tomography/computed tomography
por: Aksoy, Sabire Yilmaz, et al.
Publicado: (2016)

Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography in addition to magnetic resonance imaging and single-photon emission computed tomography on diagnosis of mild cognitive impairment to Alzheimer's disease
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Analysis of amyloid and tau deposition in Alzheimer's disease using (11)C-Pittsburgh compound B and (18)F-THK 5351 positron emission tomography imaging
por: Chanisa, Chotipanich, et al.
Publicado: (2020)

Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
por: Ni, Ruiqing, et al.
Publicado: (2022)

Positron emission tomography; viable tool in patients pre-CABG?
por: van der Wall, E. E., et al.
Publicado: (2010)

Novel Positron Emission Tomography Tracers for Imaging Vascular Inflammation
por: Ćorović, Andrej, et al.
Publicado: (2020)

Radiochemistry for positron emission tomography
por: Rong, Jian, et al.
Publicado: (2023)

Positron emission tomography alone, positron emission tomography-computed tomography and computed tomography in diagnosing recurrent cervical carcinoma: a systematic review and meta-analysis
por: Xiao, Yi, et al.
Publicado: (2014)

Comparative examination of the pons and corpus callosum as reference regions for quantitative evaluation in positron emission tomography imaging for Alzheimer’s disease using (11)C-Pittsburgh Compound-B
por: Tada, Tomohiro, et al.
Publicado: (2023)

Positron emission tomography
Publicado: (1995)

Positron Emission Tomography
por: Piepmeier, Joseph M.
Publicado: (1986)

Positron emission tomography
por: Paans, A M J
Publicado: (2006)

Pittsburgh Conference
por: Collective
Publicado: (1992)

Pittsburgh Conference
Publicado: (1993)

Pittsburgh Conference
por: Collective
Publicado: (1994)

Pittsburgh Conference
por: Thompson, Julia
Publicado: (1992)

Pittsburgh Conference
por: Collective
Publicado: (1995)

Pittsburgh Conference
por: Collective
Publicado: (1996)

Pittsburgh Dentists
Publicado: (1852)

Pittsburgh Landing
Publicado: (1862)

Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia
por: Ricci, Maria, et al.
Publicado: (2020)

(18)F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer
por: You, J J, et al.
Publicado: (2015)

Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review
por: de Wilde, Arno, et al.
Publicado: (2018)

Positron emission tomography: basic sciences
por: Bailey, D L, et al.
Publicado: (2003)

AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2016)

Positron emission tomography: clinical practice
por: Valk, Peter E, et al.
Publicado: (2006)

Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
por: Khoonsari, Payam Emami, et al.
Publicado: (2019)

Positron emission tomography: An overview
por: Shukla, A. K., et al.
Publicado: (2006)

Scintillators for positron emission tomography
por: Moses, W W, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_n04j93c9ecc1o17jmfctj577fh